AstraZeneca’s Lynparza to dominate PARP inhibitors market with $4 bn in sales by 2027: GlobalData Read more
New Drug Application of Zydus’ Desidustat tablets by China Medical System Holdings accepted in China Read more
Top 20 global biopharma companies report 9.6 per cent market cap growth in Q1 2024: GlobalData Read more